Effectiveness and Risk Factors for Virological Outcome of Raltegravir-Based Therapy for Treatment-Experienced HIV-Infected Patients

OBJECTIVE: We evaluated the effectiveness of a raltegravir (RAL)-containing regimen plus an optimized background regimen in HIV-1 highly treatment-experienced patients. DESIGN: A retrospective cohort, multicentre study was conducted. METHODS: Adult (>16 years old) HIV treatment-experience patient...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Drugs R D
Egile Nagusiak: Mata-Marín, José Antonio, Smeke, Ariane Estrella Weiser, Rodriguez, Mariana Rotzinger, Chávez-García, Marcelino, Banda-Lara, Marco Isaac, Rios, Alma Minerva Pérez, Nuñez-Rodríguez, Nohemí, Domínguez-Hermosillo, Juan Carlos, Sánchez, Alberto Chaparro, Juarez-Kasusky, Irene, Herrera, Javier Enrique Cruz, Ramírez, Jorge Luis Sandoval, Gaytán-Martínez, Jesús
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Springer International Publishing 2017
Gaiak:
Original Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5318342/
https://ncbi.nlm.nih.gov/pubmed/28124232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40268-017-0174-z
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak